glp-1 heart issues The cardiovascular effects of receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action GLP-1 medicines may cut clot-related

This way, they can keep an eye on their health and change treatments if needed

R&D and Innovation: Pharmaceutical companies are continuing to invest in the development and innovation of GLP-1RA drugs that should lead to increased efficacy, further use cases and reduced side effects

My doctor even told me that some foods might help with weight loss, but they dont do anything for blood sugar control, which was so disheartening

Tirzepatide (Mounjaro, Zepbound) Strengths: Highest efficacy for both glucose control and weight loss Dual mechanism (GLP-1 + GIP) may provide unique benefits Once-weekly dosing Generally well-tolerated Considerations: Higher cost than semaglutide Less long-term safety data (newer medication) Cardiovascular outcome trial not yet complete (though expected to be positive) Best for: Patients prioritizing maximum weight loss